Sinopharm
1099.HK
#1963
Rank
C$11.43 B
Marketcap
$3.66
Share price
-0.25%
Change (1 day)
6.30%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.56

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.56. In 2022 the company made an earnings per share (EPS) of $0.56 an increase over its 2021 EPS that were of $0.55.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.561.3%
2021$0.5510.33%
2020$0.5017.26%
2019$0.435.44%
2018$0.40-0.87%
2017$0.4119.44%
2016$0.3415.3%
2015$0.3017.06%
2014$0.2521.9%
2013$0.2111.82%
2012$0.1925.24%
2011$0.1531.02%
2010$0.113.3%
2009$0.1146.85%
2008$0.0744467.57%
2007$0.04442310.24%
2006$0.01083